Ethnic and racial differences in Asian populations with ion channelopathies associated with sudden cardiac death

Sahil Zaveri1,2, Yongxia Sarah Qu1,2,3, Mohamed Chahine4,5

  • 1Department of Medicine, Cell Biology, and Pharmacology, State University of New York Downstate Health Sciences University, Brooklyn, NY, United States.

Insights

This review highlights ethnic and racial disparities in cardiovascular disease, focusing on sudden cardiac death (SCD) and ion channelopathies in Asian populations. It addresses unique genetic risks and proposes solutions for equitable care.

Area of Science:

  • Cardiology
  • Genetics
  • Public Health

Background:

  • Cardiovascular diseases are a leading cause of global mortality.
  • Ethnic and racial disparities exist in cardiovascular disease treatment and outcomes.
  • Sudden cardiac death (SCD) and ion channelopathies show ethnic variations, complicating patient care.

Purpose of the Study:

  • To review and synthesize research on cardiac ion channelopathies and genetic disorders in Asian populations.
  • To examine ethnic and racial differences in SCD and ion channelopathies between Asian and White populations.
  • To identify unique genetic risk factors and propose solutions for underrepresented Asian populations.

Main Methods:

  • Literature review and synthesis of current research.
  • Analysis of studies on cardiac ion channelopathies and SCD in Asian populations.
  • Comparison of genetic risk factors, treatment, and outcomes between Asian and White populations.

Main Results:

  • Asian populations are underrepresented in cardiovascular literature regarding SCD and ion channelopathies.
  • Ethnic differences exist in research, treatment, and outcomes for cardiac ion channelopathies.
  • Unique genetic risk factors contribute to SCD in Asian populations.

Conclusions:

  • Addressing disparities in SCD and ion channelopathies requires improved genetic screening and access to care for Asian populations.
  • Enhanced physician training and patient education are crucial for managing cardiac genetic disorders.
  • Further research is needed to understand and mitigate ethnic and racial differences in cardiovascular disease outcomes.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
950
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.3K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
Dysrhythmias I: Introduction01:15

Dysrhythmias I: Introduction

Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
14
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
6.0K